Author:
Kang Minseo,Youn Ho Geun,An Ji Yeong,Choi Min-Gew,Lee Jun Ho,Sohn Tae Sung,Bae Jae Moon,Kim Sung
Publisher
Springer Science and Business Media LLC
Reference18 articles.
1. Noh SH, Park SR, Yang H-K et al. Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial. Lancet Oncol. 2014; 15:1389–96.
2. Sasako M, Sakuramoto S, Katai H et al. Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol. 2011; 29: 4387–93.
3. Sobin LH, Wittekind C, Union internationale contre le Cancer. TNM classification of malignant tumours. Wiley-Liss, New York; 2002.
4. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer. Japanese Gastric Cancer Association; 2020.
5. Edge S, Byrd DR, Compton CC, Fritz AG (eds). AJCC cancer staging handbook: from the AJCC cancer staging manual. 7th ed. Springer, New York; 2009.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献